Stoppelli, Maria Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 891
AS - Asia 811
SA - Sud America 328
EU - Europa 175
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.259
Nazione #
US - Stati Uniti d'America 812
SG - Singapore 265
BR - Brasile 247
CN - Cina 169
BD - Bangladesh 134
IT - Italia 127
VN - Vietnam 65
HK - Hong Kong 43
IN - India 36
MX - Messico 34
CA - Canada 29
AR - Argentina 23
IQ - Iraq 21
MA - Marocco 17
CO - Colombia 15
FR - Francia 15
VE - Venezuela 13
EC - Ecuador 12
ID - Indonesia 12
PK - Pakistan 12
ZA - Sudafrica 12
TR - Turchia 11
PY - Paraguay 7
RU - Federazione Russa 7
TN - Tunisia 6
GB - Regno Unito 5
MY - Malesia 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CR - Costa Rica 4
JM - Giamaica 4
JO - Giordania 4
KE - Kenya 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
DE - Germania 3
EG - Egitto 3
NL - Olanda 3
UY - Uruguay 3
BY - Bielorussia 2
CL - Cile 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
JP - Giappone 2
KZ - Kazakistan 2
MR - Mauritania 2
NP - Nepal 2
PE - Perù 2
PL - Polonia 2
TH - Thailandia 2
UA - Ucraina 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BS - Bahamas 1
BW - Botswana 1
CU - Cuba 1
DK - Danimarca 1
DZ - Algeria 1
ES - Italia 1
FI - Finlandia 1
GH - Ghana 1
GM - Gambi 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
LY - Libia 1
MN - Mongolia 1
NI - Nicaragua 1
OM - Oman 1
PF - Polinesia Francese 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SE - Svezia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.259
Città #
San Jose 412
Ashburn 134
Singapore 132
Beijing 55
Rome 43
Hong Kong 42
Mexico City 26
Santa Clara 25
Ho Chi Minh City 24
São Paulo 20
Hanoi 13
New York 11
Baghdad 8
Buffalo 8
Houston 8
Dallas 7
Milan 7
Rio de Janeiro 7
Casablanca 6
Salvador 6
Toronto 6
Atlanta 5
Brooklyn 5
Caracas 5
Dax 5
Hyderabad 5
Mumbai 5
Quito 5
Belo Horizonte 4
Bologna 4
Brasília 4
Charlotte 4
Erbil 4
Johannesburg 4
London 4
Nairobi 4
Naples 4
San José 4
Tashkent 4
Amman 3
Antakya 3
Cabo Frio 3
Cairo 3
Cape Town 3
Chicago 3
Curitiba 3
Dhaka 3
Figino 3
Florence 3
Fortaleza 3
Frankfurt am Main 3
Goiânia 3
Jaboatão dos Guararapes 3
Jakarta 3
Jersey City 3
Karachi 3
Los Angeles 3
São Bernardo do Campo 3
Washington 3
Abu Dhabi 2
Addis Ababa 2
Ananindeua 2
Aprilia 2
Asunción 2
Augusta 2
Baku 2
Barquisimeto 2
Bengaluru 2
Biên Hòa 2
Cachoeirinha 2
Catalão 2
Chieti 2
Ciudad del Este 2
Cochabamba 2
Contagem 2
Dartmouth 2
Delhi 2
Denver 2
El Jadida 2
Faisalabad 2
Fort Lauderdale 2
Foz do Iguaçu 2
Guarapuava 2
Guayaquil 2
Haiphong 2
Hialeah 2
Hortolândia 2
Indaiatuba 2
Itabuna 2
Kuala Lumpur 2
Lahore 2
Ludhiana 2
Magé 2
Mar del Plata 2
Medellín 2
Miami 2
Minsk 2
Mogi Guaçu 2
Montevideo 2
Montreal 2
Totale 1.221
Nome #
Paracrine recruitment and activation of fibroblasts by c-Myc expressing breast epithelial cells through the IGF/IGF-1R axis 61
Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide 50
A reversible shift of driver dependence from EGFR to Notch1 in non-small cell lung cancer as a cause of resistance to tyrosine kinase inhibitors 50
Urokinase signalling through its receptor protects against anoikis by increasing Bcl-xL expression levels 48
Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion 48
Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies 45
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 45
Optic nerve head and fibre layer imaging for diagnosing glaucoma 42
Inhibiting monocyte recruitment to prevent the pro-tumoral activity of tumor-associated macrophages in chondrosarcoma 42
Inhibition of migration and invasion of carcinoma cells by urokinase-derived antagonists of αvβ5 integrin activation 41
An urokinase receptor-derived peptide inhibiting VEGF-dependent directional migration and vascular sprouting 39
Histone deacetylase inhibitors impair vasculogenic mimicry from glioblastoma cells 37
An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor 37
Autocrine saturation of pro-urokinase receptors on human A431 cells 37
Dp100 EGF and insulin binding protein from Drosophila cells 37
Nuovi peptidi e peptidomimetici come agenti potenti e mirati nella prevenzione e nel trattamento dell'invasione e metastasi tumorali 37
Characterization of a Drosophila protein that binds both Epidermal Growth Factor and insulin-related growth factors 36
Biological role and clinical relevance of extracellular vesicles as key mediators of cell communication in cancer 35
Developmental regulation of an insulin degrading enzyme in Drosophila melanogaster 35
Differentiation-enhanced binding of the aminoterminal fragment of of human urokinase plasminogen activator to a specific receptor on U937 monocytes 35
An insulin epidermal growth factor-binding protein from Drosophila has insulin-degrading activity 35
Reversal of Warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non small cell lung cancer 34
Urokinase receptor promotes ovarian cancer cell dissemination through its ser88-arg-ser-arg-tyr92 chemotactic sequence 34
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma 33
RhoB regulates uPAR signalling 33
Inhibition of receptor-dependent urokinase signaling by specific ser to glu substitutions 33
Vitronectin binding to urokinase receptor in human breast cancer 32
Phosphorylation of urokinase is not a limiting step in biosynthesis, but results in a reduced PAI-1 sensitivity 32
PHOSPHORYLATED PLASMINOGEN ACTIVATORS AND NOVEL MUTEINS RELATED TO THE PHOSPHORYLATED PLASMINOGEN ACTIVATORS 32
Proteases and cancer invasion: from belief to certainty 31
A recombinant pro-urokinase missing the growth factor-like domain does not bind the urokinase receptor 31
Engaged urokinase receptors enhance tumor breast cell migration and invasion by upregulating αvβ5 vitronectin receptor cell surface expression 31
Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography. Comparison with urokinase levels 31
Developmental regulation of an insulin/ EGF binding protein in Drosophila 30
Protein kinase C-dependent in vivo phosphorylation of prourokinase leads to the formation of a receptor competitive antagonist 30
Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and αvβ5 integrin 30
Molecular cloning of human urokinase cDNA: transcriptional regulation in A431 cells 30
Opposite modulation of cell migration by distinct subregions of urokinase connecting peptide 30
The urokinase receptor: structure, regulation and inhibitor-mediated internalization 29
MiR-204 targeting of Ankrd13A controls both mesenchymal neural crest and lens cell migration 28
Modulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptor 28
Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA 28
MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p 28
Analysis of secretome changes uncovers an autocrine/paracrine component in the modulation of cell proliferation and motility by c-Myc 28
The soluble form of urokinase receptor promotes angiogenesis through its Ser⁸⁸-Arg-Ser-Arg-Tyr⁹² chemotactic sequence 26
αV-Integrin-Dependent Inhibition of Glioblastoma Cell Migration,Invasion and Vasculogenic Mimicry by the uPAcyclin Decapeptide 26
Serine phosphorylation of biosynthetic human urokinase plasminogen activator 25
A novel localization in human large extracellular vesicles for the EGF-CFC founder member CRIPTO and its biological and therapeutic implications 25
EGF and insulin related growth factors compete for binding to a single Drosophila protein 25
Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells 25
Inhibition of Sp1 activity by a decoy PNA-DNA chimera prevents urokinase receptor expression and migration of breast cancer cells 24
The receptor binding sequence of human urokinase 24
In vitro receptor imaging for characterization of human solid tumors 24
Specificity and properties of the human urokinase receptor 24
Phosphorylation of pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adhesion and motility 24
Phosphorylation of seminal vesicle protein IV on Ser58 enhances its peroxidase-stimulating activity 23
Urokinase receptor-dependent and independent p56/59hck activation state is a molecular switch between myelomonocytic cell motility and adherence 23
Urokinase receptor interacts with αvβ5 vitronectin receptor promoting urokinase-dependent cell migration in breast cancer 23
Separation and characterization of non phosphorylated and serine phosphorylated pro-urokinase.Catalytic properties and sensitivity to PAI-1 23
Engineered antagonists of uPA and PAI-1 23
Regulation of cell migration and invasion by specific modules of uPA: mechanistic insights and specific inhibitors 22
Transcriptional induction of urokinase in cultured human kidney carcinoma cells by tetradecanoyl-phorbol acetate 22
Phorbol ester PMA regulates the affinity and the number of the urokinase receptors in monocyte-like U937 cells 22
Structure, function and antagonists of urokinase-type plasminogen activator 21
The receptor for human urokinase-plasminogen activator 21
Modulation of cellular function by the urokinase receptor signalling: a mechanistic view 21
The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis 21
Increase in urokinase plasminogen activator mRNA in human carcinoma cells is a primary effect of the potent tumor promoter phorbol myristate acetate 20
The urokinase-type plasminogen activator and the generation of inhibitors of urokinase activity and signaling 20
Preliminary studies on the structure and regulation of the human urokinase gene: effect of tumor promoters, EGF and transformation by SV40 20
Molecular biology of plasminogen activation and its role in the invasivness of malignant cells 20
Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion 20
Molecular basis for plasminogen activation, surface proteolysis and their relation to cancer 19
The receptor binding sequence of urokinase: biological function for the growth factor module of proteases 18
The Plasminogen Activation System in Cell Invasion 18
Praf2 is a novel Bcl-xL/Bcl-2 interacting protein with the ability to modulate survival of cancer cells 18
Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer 18
Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis 17
Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells 14
Totale 2.337
Categoria #
all - tutte 9.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.284


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025438 0 0 0 0 0 0 0 1 1 117 156 163
2025/20261.853 74 6 135 129 145 81 172 72 370 234 246 189
2026/202746 46 0 0 0 0 0 0 0 0 0 0 0
Totale 2.337